TrialNeuro-oncology2021

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.

Hao-Wen Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.